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OBJECTIVES The effects of long-term cardiac resynchronization therapy (CRT) on left ventricular (LV)
energetics and metabolic reserve were evaluated.
BACKGROUND Cardiac resynchronization therapy is a new therapy for patients with drug-refractory severe
heart failure (HF).
METHODS Ten patients with idiopathic dilated cardiomyopathy who had undergone implantation of
biventricular pacemaker 8  5 months earlier were studied during two conditions: CRT
switched on, and after CRT was switched off for 24 h. Left ventricular function was measured
using echocardiography and oxidative metabolism using [11C]acetate positron emission
tomography. Both measurements were performed at rest and during dobutamine-induced
stress (5 g/kg/min). Basal- and adenosine-stimulated (140 g/kg/min) myocardial blood
flow were quantitated using [15O]water.
RESULTS During CRT off, LV stroke volume was significantly reduced at rest (72  18 ml vs. 63 
15 ml, p 0.05), but LV oxidative metabolism (Kmono) remained unchanged (0.046 0.008
vs. 0.054  0.016 min1) leading to a significant deterioration of myocardial efficiency of
forward work (from 48.2  16.7 to 36.6  11.7 mm Hg·l/g, p  0.05). During
dobutamine-induced stress, stroke volume and Kmono values were not different whether CRT
was on or off. However, myocardial efficiency (56.1  16.1 vs. 49.8  18.0 mm
Hg·ml·g1·min1, p  0.099) and metabolic reserve, the response of Kmono to dobutamine
(0.023  0.014 vs. 0.013  0.014 min1, p  0.09), tended to reduce when CRT was
switched off. Cardiac resynchronization therapy had no effects on myocardial perfusion.
Natriuretic peptides increased significantly during CRT-off period.
CONCLUSIONS Long-term CRT has beneficial effects on LV function and myocardial efficiency at rest in
patients with HF. These effects are not associated with changes in myocardial perfusion
or oxygen consumption. During dobutamine-induced stress, CRT does not affect
functional parameters, but myocardial efficiency and metabolic reserve may be
increased. (J Am Coll Cardiol 2004;43:1027–33) © 2004 by the American College of
Cardiology Foundations
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whe incidence of patients with heart failure (HF) has
ncreased exponentially over the last decade and has become
n enormous public health problem (1). Besides coronary
rtery disease, idiopathic dilated cardiomyopathy is fre-
uently the underlying cause of chronic HF. Despite ad-
ances in medical therapy (-blockers, angiotensin-
onverting enzyme inhibitors, spironolactone), many
atients remain severely symptomatic. Cardiac resynchroni-
ation therapy (CRT) is a recently introduced technique to
mprove the treatment of patients with HF and intraven-
ricular conduction delay. Cardiac resynchronization ther-
py has beneficial effects on left ventricular (LV) function,
From the *Turku PET Centre and †Departments of Medicine, University of
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ardiology, Leiden University, Leiden, the Netherlands. Supported by grants from
urku University Hospital (EVO), Finnish Foundation for Cardiovascular Research,
nd Medtronic Inc.
Manuscript received March 26, 2003; revised manuscript received June 26, 2003,ccepted October 13, 2003.ymptoms, and exercise capacity, and it may even improve
rognosis (2–8). However, limited data are available about
he long-term effects of CRT on myocardial energetics,
etabolic reserve, and perfusion.
Positron emission tomography (PET) enables the mea-
uring of myocardial oxidative metabolism and blood flow
oninvasively, qualitatively, and accurately in humans
2,9,10). The present PET study was designed to evaluate
he long-term effects of CRT on LV function, oxidative
etabolism, forward work efficiency, myocardial perfusion,
nd natriuretic peptide concentrations. In addition to the
esting studies, all measurements were repeated during
obutamine-induced pharmacologic stress. The perfor-
ance of the measurements during dobutamine infusion
rovides insight into the responses of all aforementioned
arameters during stress. In particular, no data are currently
vailable on the performance of CRT in combination with
tress; all previous studies evaluating the response to CRT
ere performed under resting conditions.
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ubjects. The characteristics of the patients are summa-
ized in Table 1. Ten subjects with symptomatic HF and
diopathic dilated cardiomyopathy (LV ejection fraction
45%, left bundle branch block) were included. Before
RT, New York Heart Association (NYHA) class was
III, QRS duration 140 ms (175  25 ms), and LV
jection fraction 35% (25  6%) in the study subjects.
he patients underwent implantation of a biventricular
acemaker 8  5 months before the study. Six patients had
eceived a DDD-based biventricular pacemaker, and four
ad a DDD-based biventricular pacemaker/defibrillator de-
ice. No patients had atrial fibrillation or atrioventricular
onduction disorders. All patients were clinically stable,
reated with CRT and optimal medical therapy, and did not
ave evidence of decompensated HF at the time of the
tudy. The study was conducted according to the guidelines
f the Declaration of Helsinki, and the Ethics Committee
f the Turku University Central Hospital accepted the study
rotocol. Each subject gave written informed consent.
tudy design. The study was performed at the Turku PET
entre (Turku University Central Hospital, Turku, Fin-
and) in a randomized, blinded fashion. The dose of
-blockade was gradually reduced during six days before the
ET studies (to avoid rebound effect), withdrawn com-
Abbreviations and Acronyms
CRT  cardiac resynchronization therapy
HF  heart failure
Kmono  [
11C]acetate clearance rate
LV  left ventricle
NYHA  New York Heart Association
PET  positron emission tomography
ROI  region of interest
S-ANPN  serum N-terminal atrial natriuretic peptide
S-proBNP  serum N-terminal pro-brain natriuretic
peptide
[11C]acetate  carbon-11-labeled acetate
[15O]water  oxygen-15-labeled water
able 1. Characteristics of the Patients (Mean [SD])
ender (M:F) 8:2
ge (yrs) 59 (11)
ody mass index (kg/m2) 31.5 (4.8)
V ejection fraction (%) 32.2 (7.9)
V mass (g) 315.1 (97.7)
itral regurgitation grade 1.9 (0.9)
lood pressure (mm Hg) 114/72 (13/8)
YHA class 2.3 (0.5)
RS duration (ms) 135 (16)
edications
Diuretics 10/10
ACE inhibitors 6/10
Angiotensin II blocker 4/10
-blockers 10/10
Digoxin 1/10
CE  angiotensin-converting enzyme; LV  left ventricle; NYHA  New York
oeart Association.letely two days before the PET studies, and restarted again
fter the PET studies. This was done to avoid antagonistic
ctions of -blockade on the effects of dobutamine. Other
ardiac medication was continued during the PET studies.
ll PET studies were performed after an overnight fast.
dditionally, the patients were instructed to avoid all
affeine-containing drinks and foods for 12 h before the
ET studies.
The study design is illustrated in a schematic manner in
igure 1. All study procedures were completed under the
ame conditions, and the patients were studied at the same
ime of day. Each patient was studied on two separate
ccasions: during CRT and after CRT was switched off for
4 h (which was considered an ethically acceptable period in
he patients with severe HF) before the PET studies. The
acing mode of the two study days was performed in a
andom order. Serum N-terminal atrial natriuretic peptide
S-ANPN) and N-terminal pro-brain natriuretic peptide
S-proBNP) were determined immediately preceding the
ET studies. Myocardial perfusion was measured using
xygen-15-labeled water (15O-water) and PET, at rest and
hen after administration of adenosine. Thereafter, oxidative
etabolism of the LV measured by carbon-11-labeled
cetate ([11C]acetate) and PET was quantitated at baseline
nd during dobutamine infusion. To determine systolic LV
unction, two-dimensional echocardiography was per-
ormed at rest and during dobutamine infusion. One patient
id not tolerate dobutamine because of severe arrhythmias,
nd, therefore, studies during dobutamine infusions were
erformed in 9 of 10 patients. The subjects’ electrocardio-
ram and heart rate were monitored continuously during the
tudies. Blood pressure was monitored throughout the
rocedures with an automatic oscillometric blood pressure
onitor (OMRON HEM-705C, Omron Healthcare,
amburg, Germany) during all PET studies. The analyses
igure 1. Study design: patients were studied on two separate occasions:
hile cardiac resynchronization therapy (CRT) was switched on and after
RT was switched off for 24 h. Serum natriuretic peptides were measured
mmediately preceding the positron emission tomography (PET) studies.
yocardial blood flow was quantitated using PET and [15O]water
[15O]H2O) at baseline and during adenosine infusion (140 g/kg/min for
.5 min). Left ventricular oxidative metabolism was measured using PET
nd [11C]acetate at baseline and during low-dose dobutamine infusion (5
g/kg/min for 60 min). Left ventricular function was measured using
wo-dimensional echocardiography first at rest and then during dobut-
mine infusion. Open bars  perfusion measurement; solid bars 
xidative metabolism measurement.f PET data and echocardiograms were performed blinded.
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March 17, 2004:1027–33 Effects of Cardiac Resynchronization Therapychocardiographic examination. All echocardiographic
ecordings and analyses were performed by the same expe-
ienced investigator (E.E.) using a commercially available
ltrasound scanner (Acuson Sequoia C 256, Siemens,
ountain View, California). Standard echocardiographic
iews of the LV were obtained, and end-diastolic and
nd-systolic LV dimensions, volumes, and LV mass were
etermined. Left ventricular dimensions were measured
ccording to the American Society of Echocardiography
ecommendations, and LV mass was calculated by the cube
ormula and using the correction formula proposed by
evereux et al. (11). Left ventricular stroke volumes were
easured from the LV outflow tract using pulsed Doppler
easurements. The outflow tract diameter was measured in
he first study, and the area was calculated assuming a
ircular configuration. The same area was used in all
ubsequent studies. The sample volume was positioned at
he same distance from the transducer and aortic valve. Left
entricular wall stress was calculated according to the
quation: WS  (p  r)/[2Wth  (1 Wth/2r)] in which
is systolic blood pressure, r is systolic internal radius of the
V, and Wth is systolic wall thickness. The echocardio-
rams were recorded at baseline before the PET studies and
uring dobutamine infusion immediately after the last PET
Table 2. Hemodynamic Data During PET Stu
[15O]wate
Basal
Heart rate (beats/min)
CRT on 73 (9)
CRT off 71 (12)
Systolic bp (mm Hg)
CRT on 115 (14)
CRT off 117 (16)
Diastolic bp (mm Hg)
CRT on 70 (6)
CRT off 71 (9)
RPP (mm Hg/min)
CRT on 8,291 (1,248) 10
CRT off 8,206 (1,203) 9
*p  0.05 vs. basal.
bp  blood pressure; CRT  cardiac resynchronization
igure 2. Cardiac resynchronization therapy (CRT) enhanced left ventric-
lar stroke volume significantly at baseline but not during dobutamine-
nduced stress. Open bars  CRT on; solid bars  CRT off.can. External, or forward, LV work power was calculated
s: systolic blood pressure  stroke volume  heart rate.
easurement of myocardial perfusion and oxidative
etabolism. The positron emitting tracers [15O]water and
11C]acetate were produced as previously described (10).
he subjects were positioned supine in a 15-slice ECAT
31/08-12 tomograph (Siemens/CTI Inc., Knoxville, Ten-
essee). After the transmission scan, myocardial perfusion
as measured with an intravenous injection of [15O]water
1.5 GBq) at rest and 60 s after intravenous administra-
ion of adenosine (140 g/kg/min for 7.5 min intrave-
ously). Each dynamic scan lasted for 6 min (6 5, 6 15,
 30 s). Thereafter, an intravenous bolus of [11C]acetate
724  19 MBq) was administered simultaneously with the
tart of a 29-min (10  10, 1  60, 5  100, 5  120, 2
240 s) dynamic emission scan. After tracer decay,
11C]acetate PET was repeated during dobutamine infusion
for 1 h, at an infusion rate of 5 g/kg/min). All data were
orrected for dead time, radioactive decay, and photon
ttenuation. Images were processed using an iterative me-
ian root prior reconstruction algorithm (12).
nalysis and calculation of myocardial blood flow and
oronary flow reserve. On the myocardial [15O]water im-
ges, a region of interest (ROI) was drawn in the whole wall
including the lateral, anterior, and septal parts) of the LV
n four representative transaxial slices in each study as
reviously described (13). The ROI outlined in the baseline
mages was copied to the images obtained after adenosine
dministration. Values of myocardial blood flow (expressed
n ml/g of tissue per min) were calculated according to the
reviously published method using the single compartment
odel (14). The arterial input function was obtained from
he LV time-activity curve using a previously validated
ethod (15) in which corrections were made for the limited
ecovery of the LV ROI and the spillover from the myo-
ardial signals. The average blood flow of the whole wall of
he LV was used in further analysis. Coronary flow reserve
(Mean [SD])
[11C]Acetate
osine Basal Dobutamine
(19)* 71 (9) 93 (19)*
(14)* 71 (11) 94 (22)*
(14) 113 (11) 123 (19)
(11) 114 (17) 122 (25)
(10) 72 (11) 71 (12)
(7) 73 (9) 70 (11)
(2,998)* 8,014 (1,094) 10,286 (4,494)*
(1,692)* 8,024 (1,460) 10,184 (4,359)*
y; RPP  rate pressure product (systolic bp  heart rate).dies
r
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,342
,520
therap
w
a
A
m
w
B
e
r
L
t
w
K
A
a
i
c
o
p
c
h
G
S
S
c
g
s
w
C
R
H
b
v
T
s
E
i
T
s

d
C
o
v
M
M
s
0
a
m
S
r
M
v
m
s
0
m
C
m
i
F
e
F
c
i
1030 Sundell et al. JACC Vol. 43, No. 6, 2004
Effects of Cardiac Resynchronization Therapy March 17, 2004:1027–33as defined as the ratio of the myocardial blood flow during
denosine infusion to flow at baseline.
nalysis and calculation of oxidative metabolism and
yocardial efficiency. Myocardial [11C]acetate studies
ere analyzed with the MunichHeart software (16,17).
riefly, monoexponential fitting was applied, and [11C]ac-
tate clearance rate (Kmono) was calculated. In each patient,
econstructed PET tomograms were evaluated, and global
V Kmono was determined. Myocardial efficiency (the rela-
ion between the forward work and oxygen consumption)
as estimated as: forward LV work power per gram/LV
mono.
ssessment of natriuretic peptide. Serum N-terminal
trial natriuretic peptide was measured using an in-house
mmunofluorometric assay method (reagents: Medix Bio-
hemica, Espoo, Finland; instrument: Delfia Research Flu-
rometer; Wallac, Turku, Finland). Serum N-terminal
ro-brain natriuretic peptide was measured using an electro-
hemiluminometric method (reagent kit: Roche, Mann-
eim, Germany; instrument: Elecsys, Roche, Mannheim,
ermany; analyzed at Limbach Laboratory, Germany).
tatistical analysis. The results are expressed as mean 
D. Student paired t test was used within the group
omparisons, and Student unpaired t test when two different
roups were compared. A p value0.05 were interpreted as
tatistically significant. All statistical tests were performed
ith SAS statistical analysis system (SAS Institute Inc.,
ary, North Carolina).
ESULTS
emodynamic measurements during PET. Heart rates,
lood pressures, and rate-pressure products during the
igure 3. Cardiac resynchronization therapy (CRT) had no significant
Table 3. Echocardiographic Parameters (Mean
CRT
Basal
OFF
Heart rate (beats/min) 73 (14)
Cardiac output (l/min) 4.6 (1.2)
LVdd (mm) 74 (9)
LVds (mm) 62 (8)
Wall stress (mm Hg) 820 (320)
*p  0.05 vs. respective basal value; †p  0.1 vs. CRT OFF
LVdd  left ventricle end-diastolic diameter; LVds  leffect on basal- or adenosine-stimulated myocardial blood flow. sarious parts of the PET study protocol are presented in
able 2. Adenosine and dobutamine infusions induced a
ignificant increase in heart rate and rate-pressure products.
chocardiographic parameters. Stroke volumes are shown
n Figure 2, and other echocardiographic parameters in
able 3. When CRT was switched off, LV stroke volume
ignificantly reduced at rest (72  18 ml vs. 63  15 ml, p
0.04). Dobutamine infusion increased cardiac output and
ecreased LV end-systolic diameter (p  0.05; Table 3).
ardiac resynchronization therapy had no significant effect
n LV stroke volume during dobutamine stress (79 23 ml
s. 74  24 ml, CRT on and off; p  NS; Fig. 2).
yocardial blood flow and coronary flow reserve.
yocardial blood flow values are shown in Figure 3. No
ignificant differences were detected in basal (0.7  0.2 and
.8  0.3 ml·g1·min1, CRT on and off; p  NS) or
denosine-stimulated (1.8  1.1 and 1.6  0.9
l·g1·min1, respectively; pNS) myocardial blood flow.
imilarly, CRT had no significant effect on coronary flow
eserve (2.2  1.4 and 2.0  1.0, respectively; p  NS).
yocardial oxidative metabolism and efficiency. Left
entricular Kmono values are presented in Figure 4 and
yocardial efficiency in Figure 5. At rest, LV Kmono was not
ignificantly changed by CRT (0.046  0.008 vs. 0.054 
.016 min1, CRT on and off, p  0.1; Fig. 4). Resting
yocardial efficiency was significantly deteriorated when
RT was switched off (from 48.2  16.7 to 36.6  11.7
m Hg·l·g1, p  0.02; Fig. 5).
During dobutamine infusion, Kmono values were similar,
ndependent of whether CRT was on or off (0.070  0.016
])
Dobutamine
ON OFF ON
4 (11) 95 (26)* 96 (18)*
3 (1.3)† 6.8 (2.4)* 7.5 (2.0)*
3 (10) 72 (7) 69 (9)
9 (12)† 55 (8)* 52 (11)*
0 (420) 610 (380)* 590 (380)*
ricle end-systolic diameter.
igure 4. Left ventricular (LV) oxidative metabolism (Kmono) was un-
hanged by cardiac resynchronization therapy (CRT), but dobutamine-
nduced stress significantly increased Kmono values. Open bars  CRT on;[SD
7
5.
7
5
72
.
ft ventolid bars  CRT off.
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March 17, 2004:1027–33 Effects of Cardiac Resynchronization Therapys. 0.067  0.013 min1, p  NS; Fig. 4). Myocardial
fficiency tended to decrease during dobutamine stress when
RT was switched off (from 56.1  16.1 to 49.8  18.0
m Hg·l·g1, p  0.09; Fig. 5). Dobutamine infusion
nduced a significant increase in Kmono during both condi-
ions, but the metabolic reserve, the response of Kmono to
obutamine, tended to be higher when CRT was on (Kmono
ncrease 0.023  0.014 vs. 0.013  0.014 min1, p  0.09,
RT on and off).
aboratory parameters. Serum N-terminal atrial natri-
retic peptide was 1.3  1.1 nmol/l and S-proBNP 1,268
1,080 ng/l measured immediately preceding the PET
tudy when CRT was on. When CRT had been off for
4 h, S-ANPN concentration increased significantly (to
.5  1.2 nmol/l, p  0.03), and the same trend was seen
ith S-proBNP concentration (to 1,961  1,948 ng/l, p
0.1).
ssociation of the cardiac parameters and stroke volume
esponse. In 5 of 10 patients, the increase in stroke volume
y CRT was5%. None of the cardiac parameters in Table
was significantly different between the subjects with 5%
hange than those with higher than 5% change in stroke
olume. In addition, the magnitude of the stroke volume
esponse did not associate with any of the parameters in
able 1. Furthermore, no association was detected between
hese parameters and cardiac efficiency or duration of
acing.
ISCUSSION
he present study demonstrates that, in symptomatic pa-
ients with dilated cardiomyopathy and intraventricular
onduction delay, long-term CRT has maintained its ben-
ficial effects on LV function and myocardial forward work
fficiency at rest. These effects were not associated with
hanges in myocardial perfusion or oxygen consumption.
uring dobutamine-induced pharmacologic stress, CRT
oes not induce a significant effect on functional parameters,
ut LV work efficiency and metabolic reserve may be
ncreased.
The number of patients with drug-refractory HF is
ncreasing rapidly and has become a major clinical problem,
igure 5. Cardiac resynchronization therapy (CRT) significantly increased
asal myocardial efficiency, and the same, but weaker, trend was seen
uring dobutamine-induced stress. Open bars  CRT on; solid bars 
RT off.n terms of costs and management. Cardiac resynchroniza- tion therapy is a new therapy for these patients, and an
mprovement in HF symptoms, quality of life, and exercise
apacity has been demonstrated following CRT (5–8).
oreover, in a meta-analysis of randomized controlled
rials, CRT has been found to significantly reduce HF
ospitalization and death from progressive HF (4). The
enefit of CRT may be related to improvement of systolic
unction, resynchronization, reduction of mitral regurgita-
ion, and/or reverse remodeling (5). Still, the precise mech-
nism underlying the benefit of CRT is not entirely clear.
imited previous data are available regarding the effects of
RT on LV oxidative metabolism and myocardial effi-
iency. Nelson et al. (3) found in an invasive catheterization
tudy of 10 dilated cardiomyopathy patients that short-term
entricular resynchronization enhances systolic function
hile modestly lowering energy cost. In a recent PET study
nvestigating patients with congestive HF mainly due to
oronary artery disease (n  8), Ukkonen et al. (2) found
hat long-term CRT improves LV function without in-
reasing global LV oxidative metabolism, resulting in im-
roved myocardial efficiency. In the present study, the
atients had been receiving CRT for a mean of eight
onths. During that period, the adaptive mechanisms have
een suggested to have taken place. However, when CRT
as turned off for 24 h, LV function had deteriorated,
yocardial efficiency of forward work was reduced, and
oncentrations of natriuretic peptides were increased. These
ndings indicate that CRT appears to have a clinically
ignificant long-term effect beyond its short-term responses.
Interestingly, during the CRT-off period, LV stroke
olume was decreased, but myocardial oxygen consumption
emained at the same absolute level. This inversely indicates
hat the positive effect of CRT on LV function is achieved
ithout raising energy demand. This finding is concordant
ith the results of previous short-term studies of CRT (2,3)
nd indicates the unique characteristics of this treatment.
ost inotropic HF therapies increase myocardial oxygen
onsumption and LV performance concomitantly (for ex-
mple, short-term dobutamine stimulation, as seen in the
resent study, increases LV stroke volume but also signifi-
antly increases myocardial oxygen consumption, which, in
he long-term, may be considered a detrimental effect).
In the present study, we also investigated myocardial
erfusion and coronary flow reserve. Coronary flow reserve
anges about 3 to 5  the baseline values in healthy subjects
18). In concordance with the previous studies, coronary
ow reserve was blunted in patients with dilated cardiomy-
pathy (19). However, CRT had no effect on myocardial
erfusion either at rest or during hyperemia. This further
ndicates that the mechanisms behind the improvement of
V function are not related to improved oxygen supply.
In order to investigate the effect of CRT on functional
nd metabolic reserve, all measurements were repeated
uring dobutamine infusion. The performance of the mea-
urements during dobutamine infusion provides insight into
he responses during stress, which can be considered to
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Effects of Cardiac Resynchronization Therapy March 17, 2004:1027–33etter mimic patients’ normal active life than measurements
nly during resting conditions. No data are currently avail-
ble on the performance of CRT in combination with stress,
ecause all previous studies evaluating the response to CRT
ere performed under resting conditions. The overall re-
ponse to dobutamine was blunted, indicating reduced
unctional and metabolic reserve (20), which is in agreement
ith previous studies in patients with HF. Interestingly,
troke volume and oxygen consumption were not different
hether CRT was on or off during dobutamine stress.
owever, myocardial metabolic reserve, the response of
mono to dobutamine, tended to be higher when CRT was
n. In addition, myocardial efficiency tended to be higher
hen CRT was on. However, this effect appeared to be
maller during stress than at rest, suggesting that resynchro-
ization has less influence on myocardial efficiency during
tress.
Somewhat surprising, serum natriuretic peptide concen-
rations showed a significant increase 24 h after turning
RT off. The plasma concentrations have been demon-
trated to correlate with NYHA class and systolic dysfunc-
ion and also have prognostic value (21). This immediate
ncrease of natriuretic peptide concentrations rapidly after
urning off CRT further emphasizes the beneficial effects of
RT. Cardiac resynchronization therapy improves intra-
entricular contraction delay in patients with conduction
isturbances (left bundle branch block) by resynchronizing
onduction (22). The findings in the present study that
RT was able to improve LV stroke volume without
ncreasing oxygen demand suggest that cardiac dyssyn-
hrony leads to inefficient contraction and oxygen use as
elated to forward work. Although the majority of the
atients selected for CRT respond well, about 20% of the
atients’ symptoms do not improve (23). Currently, there
re no objective parameters to predict the effect of the
herapy. In the present study, we analyzed several potential
arameters, but none of them were useful to predict the
troke volume response to CRT.
tudy limitations. In the present study, we had no possi-
ility to investigate the patients before the implantation of
he biventricular pacemaker, and the CRT-off period was
nly 24 h because of safety reasons. In addition, only a
imited number of patients were investigated. However, the
tudy protocol was complicated and laborious. Despite the
imited study population and short off period, we were able
o demonstrate significant changes in myocardial energetics,
urther emphasizing the significant nature of the responses.
ow-level dobutamine stress was used in the present study,
nd it may not be possible to extrapolate our results to
igher levels of stress. However, in this kind of patient
opulation with severe HF, higher dobutamine levels or
tress are not tolerated and frequently lead to severe arrhyth-
ias. In addition, the attenuated response to dobutamine
ould have been due to the fact that patients were receiving
-blockade therapy before the study. However, -blockerherapy was gradually withdrawn two days before theeasurements, and -blocker therapy should have, at least
artially, reversed the myocardial -receptor uncoupling
nd downregulation (24). On the other hand, the effects of
RT were not studied under optimal medical therapy for
F. However, by continuing -blockers, the dobutamine
esponses would have been strikingly blunted. Further
tudies are needed to investigate these issues and the
egional effects of CRT on both the left and right ventricles.
ummary. In summary, the results of the present study
emonstrate that long-term CRT has maintained beneficial
ffects on LV function, and it enhances myocardial forward
ork efficiency at rest in patients with dilated cardiomyop-
thy and HF. These effects are not associated with changes
n perfusion or perfusion reserve and do not result in an
ncrease in myocardial oxygen consumption. During
obutamine-induced stress, CRT does not exhibit a signif-
cant effect on functional parameters, but LV work efficiency
nd metabolic reserve may be increased.
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